AEON Biopharma (AEON) 10-Q2024 Q3 Quarterly report

Filed: 13 Nov 24, 4:07pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	Coll. sophomore Bad

New words: AbbVie, adult, aesthetic, agent, analytic, analytical, ATM, biosimilar, blind, BPD, carefully, CCM, Cohen, disaggregated, discontinuation, division, double, eligible, enrolled, enrollment, ESPP, evenly, glabellar, goal, headcount, high, improvement, India, Leerink, low, Mexico, moderate, partner, pathway, payroll, placebo, pursue, randomized, receipt, reprioritization, shelf, submission, toxicology, unaffiliated

Removed: advantage, affiliate, confirming, consummate, extension, fifteen, file, good, IPO, promptly, transferred

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

AEON similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of AEON Biopharma, Inc. (the “Company”) hereby certifies, to the best of my knowledge, that:

(i)

the accompanying Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended September 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934; as amended; and

(ii)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: November 13, 2024	By:	/s/ Marc Forth
		Name:	Marc Forth
		Title:	Chief Executive Officer
			(Principal Executive and Financial Officer)

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.